泰康研究精选股票发起C(014417)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
81,363,299.99 |
6,420,195.36 |
16,302,409.82 |
-3,733,655.76 |
| 利息合计 |
368,289.09 |
228,216.85 |
162,481.61 |
70,931.74 |
| 其中:存款利息收入 |
368,289.09 |
228,216.85 |
162,481.61 |
70,931.74 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
30,775,157.87 |
4,060,790.87 |
5,866,658.31 |
-12,174,900.21 |
| 其中:股票投资收益 |
27,502,641.49 |
1,299,983.64 |
5,292,511.36 |
-12,584,758.46 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
127,456.17 |
- |
21,637.71 |
21,637.71 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,145,060.21 |
2,760,807.23 |
552,509.24 |
388,220.54 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
49,732,674.93 |
2,005,135.25 |
10,196,031.27 |
8,319,470.40 |
| 其他收入 |
487,178.10 |
126,052.39 |
77,238.63 |
50,842.31 |
| 费用 |
3,904,107.11 |
2,095,059.15 |
1,522,070.26 |
731,898.35 |
| 管理人报酬 |
2,444,126.99 |
1,292,812.96 |
931,953.55 |
441,893.10 |
| 基金托管费 |
407,354.46 |
215,468.81 |
155,325.55 |
73,648.91 |
| 销售服务费 |
905,625.55 |
513,881.44 |
334,791.08 |
158,673.18 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
147,000.00 |
72,895.94 |
100,000.00 |
57,683.08 |
| 利润总额 |
77,459,192.88 |
4,325,136.21 |
14,780,339.56 |
-4,465,554.11 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年